APA (7th ed.) Citation

S, H., R, L., BM, V., T, J., SW, B., N, A., & J, K. (2022). Mesenchymal stem cell bioenergetics and apoptosis are associated with risk for bronchopulmonary dysplasia in extremely low birth weight infants. Scientific reports, 12(1), 17484. https://doi.org/10.1038/s41598-022-22478-5

Chicago Style (17th ed.) Citation

S, Hazra, Li R, Vamesu BM, Jilling T, Ballinger SW, Ambalavanan N, and Kandasamy J. "Mesenchymal Stem Cell Bioenergetics and Apoptosis Are Associated with Risk for Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants." Scientific Reports 12, no. 1 (2022): 17484. https://doi.org/10.1038/s41598-022-22478-5.

MLA (9th ed.) Citation

S, Hazra, et al. "Mesenchymal Stem Cell Bioenergetics and Apoptosis Are Associated with Risk for Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants." Scientific Reports, vol. 12, no. 1, 2022, p. 17484, https://doi.org/10.1038/s41598-022-22478-5.